Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SCMP

(SCMP) (SCMP) Stock Price, News & Analysis

(SCMP) logo

About (SCMP) Stock (NASDAQ:SCMP)

Advanced Chart

Key Stats

Today's Range
$18.00
$18.00
50-Day Range
$18.00
$18.00
52-Week Range
$9.30
$18.75
Volume
303,068 shs
Average Volume
2.56 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Its product candidates include VTS-270, Lubiprostone (AMITIZA), Unoprostone is opropyl (RESCULA) and CPP-1X/sulindac combination product. VTS-270 is an investigational drug under clinical study for the treatment of Niemann-Pick Disease Type C-1, an ultra-orphan, progressive and fatal disease. AMITIZA is a ClC-2 chloride channel activator, which has been approved for three indications that cover distinct patient types: chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. RESCULA is a Big Potassium channel activator used to lower intraocular pressure. CPP-1X/sulindac combination product is meant for the treatment of familial adenomatous polyposis (FAP).

Receive SCMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (SCMP) and its competitors with MarketBeat's FREE daily newsletter.

SCMP Stock News Headlines

Trump Orders 'National Digital Asset Stockpile'
Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.
See More Headlines

SCMP Stock Analysis - Frequently Asked Questions

(SCMP) (NASDAQ:SCMP) announced its quarterly earnings data on Wednesday, November, 1st. The biopharmaceutical company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.02. The firm's revenue for the quarter was up 5.9% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that (SCMP) investors own include XOMA (XOMA), Sprint (SPRINT), Micron Technology (MU), SandRidge Energy (SD), AT&T (T), Vale (VALE) and Cisco Systems (CSCO).

Company Calendar

Last Earnings
11/01/2017
Today
5/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:SCMP
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:SCMP) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners